chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm bruising covering entire circumference of the upper arm from injection site to elbow / quarter size dark red bruises/circles in a straight line from elbow down to wrist; Swelling covering entire circumference of the upper arm from injection site to elbow; The patient received the third/booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old male patient received the third (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FG3527) via an unspecified route of administration in the left arm on 04Nov2021 at 11:30 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included post cerebrovascular accident (CVA), aortic stenosis, baroreceptor failure and high blood pressure (HBP). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9264) via an unspecified route of administration in the right arm on 10Feb2021 at 16:30 (at the age of 73-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 12:30 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. On 05Nov2021 at 08:00, the patient experienced arm bruising and swelling covering entire circumference of the upper arm from injection site to elbow; quarter size dark red bruises/circles in a straight line from elbow down to wrist. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event arm bruising and swelling covering entire circumference of the upper arm from injection site to elbow and quarter size dark red bruises/circles in a straight line from elbow down to wrist was not resolved at the time of this report.
At the 8 to 10 minute mark: Could not stop coughing  Lips burning and itching  At about 20 minute mark: Still coughing Swollen mouth Lips burning and itchy - took Flovent inhaler and drank water About 45 minutes Same and worse , nurse gave me 25 mg of Benadryl  After about 20 minutes coughing reduces, Swelling reduces but still itchy in moisture  Still swollen at about 30 minutes  of the Benadryl and the nurse gave me another dose of Benadryl. Symptoms started to get somewhat better I was very tired from the Benadryl  Next day my mouth was still swollen  Next day chest was very very tight and took inhaler constantly Third day after vaccine had an asthma attack, hadn?t had an asthma attack since I was in middle school. Dr prescribed prednisone and to take Zyrtec along with my inhaler I cannot return to exercise until 10 days after the start of prednisone
pt recv vax 11DEC95 & 12DEC95 pt exp pain @ inj site, swelling in arm, tingling in hand on the site that the inj was given, a low grade fever;
Information has been received from a physician concerning a female patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed breakthrough varicella. It was reported that the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Ears are plugged and I cannot hear. This has lasted about two months. It went away for a day or two then came back.   My ability to perform normal functions is severely affected. My ears seemed to be stopped up.
Shortness of breath,  elevated pulse,  dizziness, fever, and body aches
Nausea; dizziness; body ache; This is a spontaneous report from a contactable healthcare professional. A 24-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: PF13K9231), via an unspecified route of administration on the right arm on 09Jan2021 14:45 at single dose for COVID-19 immunisation.  Medical history included bipolar 2, ADHD and obesity.  Concomitant medication included sertraline, methylphenidate hydrochloride (RITALIN) and methylphenidate.  The patient experienced nausea, dizziness and body ache on 09Jan2021 19:00. The patient received no treatment. The outcome of the events was recovering.
pt recvd vax & pt went limp & lost all color-especially becoming pale around the mouth; no resp or cardiac arrest;911 called amb arrived 5-10mins later;receiving 02 for short period pt's color returned & began moving arms/legs;
p/last DT/HIB that evening vomited, next day diarrhea x 4 days, very irritable, screamed & would not sleep; Seen 6 days later @ hosp;
I had the common symptoms within 24hrs of receiving the vaccine, including headache, body aches, body chills, fever, and tiredness, which lasted approximately 24hrs. I had taken both Adderall and Allegra that day. 4 days after receiving the vaccine, I took Adderall and Allegra and had an adverse reaction (I hadn't taken Adderall the prior 3 days). I experienced palpitations and vertigo/dizziness plus slight nausea. The next day, I took a much lower dose of Adderall and decided to continue taking approximately 1/3rd of my typical dose after an E-visit with my primary care Dr. During the week of 4/5, I was able to increase the dose by a little bit without any adverse reactions. Starting on 4/11, I was able to take 2/3rds of the typical dose without adverse reaction. However, I am still experiencing vertigo/dizziness, which may or may not be sinus-related due to seasonal allergies.
Had a little bit of soreness after the booster shot, but "nothing like the kick" the second shot had; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Had a little bit of soreness after the booster shot, but "nothing like the kick" the second shot had) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. The patient's past medical history included Anxiety (He said he had a lot of anxiety.).On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Had a little bit of soreness after the booster shot, but "nothing like the kick" the second shot had). At the time of the report, MYALGIA (Had a little bit of soreness after the booster shot, but "nothing like the kick" the second shot had) outcome was unknown.    Concomitant medication was not provided.Treatment information was not provided.
The night of the shot I had nausea,  muscle weakness, sweats, shivers. Following three days arm was sore, red and swollen at injection site.
After about 45 minutes, post vax, I started to have a sick stomach and a phlegm in my throat causing me to cough and have difficulty breathing. I drank some juice and ate some bread to settle my stomach but I still was sick. After I got sick, I came to the clinic and after a little while I started feeling better. I could breath fine but my stomach was still a little upset. I feel better, though. Pt complained of single episode of vomiting with mild dizziness, abdominal cramps and extreme nausea. Pt complained of "felt phlegm" in throat with feeling a need to take a deep breath every couple of minutes. Pt's skin was slightly pale. No diaphoresis, flushing or systemic itching. No local reaction of injection site. Pt denies any self medication for nausea or cramps other than juice and bread. Pt taken to treatment room, placed in position of comfort. Pts symptoms resolved on presentation. Pt sent home with Epi-Pen and po Benadryl. Referred to allergy for evaluation.
Patient presented to urgent care on 7/28/2021 with cough and congestion with symptoms presenting about one week prior. Following chest x-ray and clinical presentation, was referred to emergency department due to concerns of pneumonia and possible COVID-19 infection.  At emergency department, was found to have fever of 102 and hypoxia. He was found to be COVID-19 positive and denied any positive contacts. He was admitted for further management.  He required treatment with dexamethasone, supplemental oxygen, and tocilizumab. He was discharged home with home health services and oxygen on 8/13/2021
Pt experienced swelling and urticarial rash 5-6 hours post vax.
Pt developed fever, joint pains, cellulitis at injection site, nausea and malaise. Resolved with conservative treatment after 4-5 days.
Intestinal problems then had break through COVID case, developed COVID was positive Monday Feb 7th.
Within 5 min of vaccine administration pt complained of chest pain, described as spasmodic & related to chest wall, & throat pain, described as similar to esophageal spasm (previously experienced). (see over).
experienced headaches; kidneys don't seem like to working properly ; problem in going to bathroom ; both peeing and pooping; kidneys don't seem like to working properly ; problem in going to bathroom ; both peeing and pooping; I am very sick; I can't remember my from taking this shot; I do not feel good/ I feel crazy; Confusion; I eat particulate and then sometimes I don't eat at all; Body ache; I felt like I was strangled in my throat like it was choking and I couldn't get over it; Sweating/sweat; I get hot that all the time in the night and it wakes me up; Feeling hot and cold; Teeth chattering; This is a spontaneous report from a contactable consumer or other non hcp (patient himself). A 65-years-old male patient received bnt162b2 (BNT162B2, formulation: solution for injection, lot number: not reported, expiry date: not reported), via an unspecified route of administration, administered in Arm Left on 05Jul2021 (at the age of 65 years) as dose 1, single for COVID-19 immunization. Medical history included drug hypersensitivity (allergic to medicines and the patient take no medicines) from an unknown date and unknown if ongoing. There were no concomitant medications. Patient had no prior vaccination within 4 weeks. Patient added "he had Headaches, a whole of bunch of confusion. His kidneys don't seem like to working properly. He has a problem in going to bathroom and in both peeing and pooping and he eat particulate and then sometimes he don't eat at all. He was very sick. He drink a lot of water but side effects confusion, body ache, he felt like he was strangled in his throat like it was choking and he couldn't get over it and finally he get whole bunch of water and then finally it went away to an extent. He can still feel it in still feel it in his throat, acting funny. He do not feel good/ he feel crazy. He can't remember his address from taking this shot. He need to see a doctor, what he need to see, all hot and cold, sweat/ sweating, he get hot that all the time in the night and it wakes him up and his teeth starts chattering, they just starts chattering away/ teeth chattering ". The patient experienced Feeling hot and cold. No treatment was received for the events. Clinical outcome of the event was reported as unknown.  The lot number for vaccine was not provided and will be requested during follow up.
Patient was administered vaccines. Upon leaving the room 5 minutes later started vomiting. Patient placed back in room, physician notified and monitored in clinic for 15 minutes.
pt recvd vax 18OCT94 & w/in 24 hrs pt devel redness, induration, swelling, & warmth @ the site of inj;
Information has been received from a physician concerning a 25 year old female who "recently" was vaccinate with the first dose of GARDASIL and fainted. The patient "came to" after she fainted the first time, and then fainted again while she was still in the office. This is one of several reports from same source. Additional information has been requested.
The patient had a vasovagal reaction to the vaccine within minutes of receiving the vaccine.  She was given smelling salts, water, juice, chocolate over a period of 30 minutes and observed while remaining seated.  She stayed at the pharmacy for an additional 30 minutes and once she felt better, she left.
muscle aches, total body soreness, tenderness at injection site, chills/low grade fever, armpit/breast area soreness.  Headache.  Fatigue.  Lasted over 24 hours without improvement.  4 days later - feeling almost better
Vaccine was maladministered via subcutaneous route instead of approved intramuscular route. Patient's wife who also received the vaccine called the morning administration after to report.
PATIENT BEGAN HAVING BACK PAIN 24 HOURS AFTER HAVING IMMUNIZATION. BACK PAIN HAS CONTINUED FOR 48 HOURS NOW. PATIENT'S GUARDIAN GIVEN INSTRUCTIONS FOR OVER THE COUNTER MEDICATION AND MONITOR CONDITION FOR CHANGES.
chills 4am 4/8 fever noon - 4/8 achiness noon 4/8
Fever, body aches and rash at injection site on 10/13. Rash travels up to her elbow. Red, hot to the touch on 10/15/12. Pt went to see her PCP and was diagnosed as having rxn to flu vaccine.
Initial report received from a healthcare professional on 09 April 2013. A 29-year-old female patient had received first intramuscular dose of ADACEL vaccine (lot number U4431AA, anatomical site of vaccination was not reported) on 09 April 2013. The patient was pregnant at the time of vaccination. The last menstrual period date was 07 July 2012 and the expected date of delivery is 30 April 2013. The patient's health during pregnancy and risk factors (e.g.: alcohol, tobacco or recreational drugs) were reported as "not applicable". As per reporter, the patient did not experience any adverse event. List of documents held by the sender: None.
48 hours after injection, patient began developing a blister like rash on his right arm. It slowly spread throughout his right chest wall and abdomen and his left leg over the course of a week.  Draining and very itchy.  Is slowly resolving with small areas of pinpoint dots on skin remining at this point.  Patient was advised use of benadryl and hydrocortisone cream which he did use.  Also used "Technu" cream and medicated Gold Bond.  If noteworthy, patient stating that he had "a very severe" case of the chicken pox as a child, requiring hospitalization.
Pt. was given MMRV and Varicella, no treatment necessary at this time. Spoke with mom today and asked how the inj. sites look. She says the RT is red and swollen on the injection site. She has been instructed to give BENADRYL for the swelling and TYLENOL or MOTRIN for discomfort.
Local reaction with itching, redness, and swelling on right thigh at the site of Flu vaccine.
course) and treatment, if any:  Headache injection site pain, swelling, burning, redness, and exhaustion, sneezing, chills, swollen lymph nodes Narrative:
Redness encircling the injection site appeared on 1/18. The redness is about 4 inches long and 3 inches wide with a darker red border around the area.
This spontaneous report as received from a pharmacist refers to a patient of unknown demographics. No concurrent conditions or medical history were provided. On 23-OCT-2014, the patient was vaccinated with the first dose of ZOSTAVAX and then was inadvertently administered a second dose of ZOSTAVAX injection (strength, dose, route of administration, lot# and expiry date unspecified for both) on 22-JAN-2015. No concomitant medications were reported. No adverse effect was reported. Additional information has been requested.
Patient recieved Injection at 2PM in the afternoon on 3/10/08 in his left Deltoid muscle. He stated to me that from the time he recieved the injection the area started to hurt and by that evening his arm started to swell from his elbow to the top of his shoulder. He stated that he could not lift his arm it was too painful. The area was swollen and painful. It kept him up all night, he also stated he had body aches with it. The symptoms lasted 2 days. He didn't report it until the third day by then the area was much better but you could see the outline of where the redness had been. He stated three of Dr.'s staff saw his arm. He had used ice to the site to relieve the swelling and pain.
A report has been received from a Pharmacist concerning a 34 year old, male subject, who had been receiving Nasal FLUMIST QUADRIVALENT. FLUMIST QUADRIVALENT started on 29-Nov-2013. It was reported that two patients were administered expired FLUMIST QUADRIVALENT on 29-Nov-2013. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious.
Pt recvd 2-1cc injects of Recombivax 3DEC90 & 17JAN91; 3JUN91 recvd Engerix-B; pt "did not develop immunity";
pt recv vax 10FEB98 & pt exp flu-like sx including severe vomiting (vomiting, blood & coffee grounds), dehydration & fever;had severe flu in ped practice geographic area;
she was diagnosed Guillain-Barre syndrome and stayed 28 days in the hospital before being discharged; She stated it started with numbness and tingling in the tongue and lips; She stated it started with numbness and tingling in the tongue and lips; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 65-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GUILLAIN-BARRE SYNDROME (hospitalization), outcome "unknown", described as "she was diagnosed Guillain-Barre syndrome and stayed 28 days in the hospital before being discharged"; HYPOAESTHESIA (hospitalization), PARAESTHESIA (hospitalization), outcome "unknown" and all described as "She stated it started with numbness and tingling in the tongue and lips". The patient was hospitalized for Guillain-Barre syndrome, hypoaesthesia, paraesthesia (hospitalization duration: 28 day(s)). The patient underwent the following laboratory tests and procedures: multiple tests: 2 lumbar punctures, notes: had multiple tests including 2 lumbar punctures; Guillain-Barre syndrome, notes: several tests and trips to the hospital, she was diagnosed Guillain-Barre syndrome. The clinical course was reported as follows: she stated it started with numbness and tingling in the tongue and lips. After several tests and trips to the hospital, she was diagnosed Guillain-Barre syndrome and stayed 28 days in the hospital before being discharged. Caller mentioned she saw 25 different neurologists and had multiple tests including 2 lumbar punctures. The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
herpes zoster; Information has been received from a lawyer, regarding a case in litigation and concerning a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions or concomitant medications was provided. On an unknown date, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unspecified date, after receiving the suspect vaccine, the pt suffered herpes zoster. As a result of these symptoms, the pt was seen and treated by medical providers and at the time of report was still under their care. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using the suspect vaccine. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of the pt's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt had suffered and incurred damages, including medical expenses, the loss of accumulations, and other economic and non-economic damages. The outcome of the event of herpes zoster was considered to be not recovered/not resolved. The lawyer considered the event to be related to zoster vaccine live (ZOSTAVAX).  The event of herpes zoster was considered to be disabling.
involuntary movement on the right index finger; This spontaneous case was reported by a consumer and describes the occurrence of DYSKINESIA (involuntary movement on the right index finger) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027620A) for COVID-19 vaccination.     Concomitant products included TERAZOSIN HYDROCHLORIDE (HYTRIN) and ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSKINESIA (involuntary movement on the right index finger). At the time of the report, DYSKINESIA (involuntary movement on the right index finger) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Aspirin.  The patient experienced involuntary movement in the index finger on right hand 2 times since receiving dose 1 of the vaccine. It occurred in the middle of the night while sleeping, woke patient up. It takes about 30 minutes to clear up. The reporter was not sure of dates, but last time was approximately 12-Feb-2021.
ON 8/6/15 PATIENT DESCRIBED SORENESS AND TROUBLE SLEEPING DUE TO PAIN FOR 3 DAYS AFTER RECEIVING VACCCINE.  SHE REPORTED THIS BECAUSE ON 8/5/15 SHE FELT A SIMILAR PAIN IN HER ARM AND ASSUMES THIS IS DUE TO THE VACCINE RECEIVED ON 1/25/15 ALTHOUGH SHE HAS HAD NO SYMPTOMS BETWEEN 1/28/15 AND 8/5/15.
Dizziness, Headache, Myalgia, Fever,  sweats, chills Narrative:
Within 1 1/2 hrs. of vaccine, I began experiencing vertigo and vomiting. These symptoms continued for about 24 hrs. I did not seek treatment.
Moderna COVID-19 Vaccine - swollen lymph node under arm left arm.  Marble sized.
1st dose, nausea, fever, aches 24 hours after vaccine. 2nd dose, numbness to left side of head and arm 1 week after vaccine
Booster shot on Jan 17, 2022. 3 Days (Jan. 20) after Covid booster, I had cramping, gas, and diarrhea. Suddenly became dairy & gluten intolerant. Very tired. Had lab tests & procedures: comprehensive bloodwork, comprehensive stool analysis, colonoscopy, endoscopy. Nothing detected from any of these that would explain this malady. Finally subsided about Sept 1. Seven months of this!